These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 28408002)

  • 1. Economic Burden of Attention-Deficit/Hyperactivity Disorder among Pediatric Patients in the United States.
    Gupte-Singh K; Singh RR; Lawson KA
    Value Health; 2017 Apr; 20(4):602-609. PubMed ID: 28408002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical Expenditures Associated with Attention-Deficit/Hyperactivity Disorder Among Adults in the United States by Age, 2015-2019.
    Witrick B; Zhang D; Su D; Li Y; McCall WV; Hendricks B; Shi L
    J Gen Intern Med; 2023 Jul; 38(9):2082-2090. PubMed ID: 36781580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parent-Reported Health Consequences and Relationship to Expenditures in Children with ADHD.
    deJong NA; Williams CS; Thomas KC
    Matern Child Health J; 2016 Apr; 20(4):915-24. PubMed ID: 26754346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attention-deficit/hyperactivity disorder: increased costs for patients and their families.
    Swensen AR; Birnbaum HG; Secnik K; Marynchenko M; Greenberg P; Claxton A
    J Am Acad Child Adolesc Psychiatry; 2003 Dec; 42(12):1415-23. PubMed ID: 14627876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health care use and costs for children with attention-deficit/hyperactivity disorder: national estimates from the medical expenditure panel survey.
    Chan E; Zhan C; Homer CJ
    Arch Pediatr Adolesc Med; 2002 May; 156(5):504-11. PubMed ID: 11980558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Children and adolescents with attention deficit-hyperactivity disorder: 1. Prevalence and cost of care.
    Burd L; Klug MG; Coumbe MJ; Kerbeshian J
    J Child Neurol; 2003 Aug; 18(8):555-61. PubMed ID: 13677583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic Impact of Headache and Psychiatric Comorbidities on Healthcare Expenditures Among Children in the United States: A Retrospective Cross-Sectional Study.
    Law EF; Palermo TM; Zhou C; Groenewald CB
    Headache; 2019 Oct; 59(9):1504-1515. PubMed ID: 31520418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health care and societal costs of the management of children and adolescents with attention-deficit/hyperactivity disorder in Spain: a descriptive analysis.
    Quintero J; Ramos-Quiroga JA; Sebastián JS; Montañés F; Fernández-Jaén A; Martínez-Raga J; Giral MG; Graell M; Mardomingo MJ; Soutullo C; Eiris J; Téllez M; Pamias M; Correas J; Sabaté J; García-Orti L; Alda JA
    BMC Psychiatry; 2018 Feb; 18(1):40. PubMed ID: 29422022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Welfare consequences for people diagnosed with attention deficit hyperactivity disorder (ADHD): A matched nationwide study in Denmark.
    Jennum P; Hastrup LH; Ibsen R; Kjellberg J; Simonsen E
    Eur Neuropsychopharmacol; 2020 Aug; 37():29-38. PubMed ID: 32682821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic impact of childhood and adult attention-deficit/hyperactivity disorder in the United States.
    Doshi JA; Hodgkins P; Kahle J; Sikirica V; Cangelosi MJ; Setyawan J; Erder MH; Neumann PJ
    J Am Acad Child Adolesc Psychiatry; 2012 Oct; 51(10):990-1002.e2. PubMed ID: 23021476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health care resource utilization and costs associated with psychiatric comorbidities in adult patients with attention-deficit/hyperactivity disorder.
    Schein J; Cloutier M; Gauthier-Loiselle M; Bungay R; Chen K; Chan D; Childress A
    J Manag Care Spec Pharm; 2024 Jun; 30(6):588-598. PubMed ID: 38824634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comorbidities and costs of adult patients diagnosed with attention-deficit hyperactivity disorder.
    Secnik K; Swensen A; Lage MJ
    Pharmacoeconomics; 2005; 23(1):93-102. PubMed ID: 15693731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization and cost of health care services for children with attention-deficit/hyperactivity disorder.
    Guevara J; Lozano P; Wickizer T; Mell L; Gephart H
    Pediatrics; 2001 Jul; 108(1):71-8. PubMed ID: 11433056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct medical and indirect absenteeism costs among working adult ADHD patients in the United States.
    Shah CH; Onukwugha E
    Expert Rev Pharmacoecon Outcomes Res; 2022 Sep; 22(6):1013-1020. PubMed ID: 35502641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000.
    Birnbaum HG; Kessler RC; Lowe SW; Secnik K; Greenberg PE; Leong SA; Swensen AR
    Curr Med Res Opin; 2005 Feb; 21(2):195-206. PubMed ID: 15801990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct medical costs of ADHD and its comorbid conditions on basis of a claims data analysis.
    Libutzki B; Ludwig S; May M; Jacobsen RH; Reif A; Hartman CA
    Eur Psychiatry; 2019 May; 58():38-44. PubMed ID: 30802682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of mental health comorbidities on health care utilization and expenditure in a large US managed care adult population with ADHD.
    Kawatkar AA; Knight TK; Moss RA; Sikirica V; Chu LH; Hodgkins P; Haim Erder M; Nichol MB
    Value Health; 2014 Sep; 17(6):661-8. PubMed ID: 25236989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The economic impact of attention-deficit/hyperactivity disorder in children and adolescents.
    Pelham WE; Foster EM; Robb JA
    Ambul Pediatr; 2007; 7(1 Suppl):121-31. PubMed ID: 17261491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Societal costs and quality of life of children suffering from attention deficient hyperactivity disorder (ADHD).
    Hakkaart-van Roijen L; Zwirs BW; Bouwmans C; Tan SS; Schulpen TW; Vlasveld L; Buitelaar JK
    Eur Child Adolesc Psychiatry; 2007 Aug; 16(5):316-26. PubMed ID: 17483870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physician Office Visits for Attention-deficit/Hyperactivity Disorder in Children and Adolescents Aged 4-17 Years: United States, 2012-2013.
    Albert M; Rui P; Ashman JJ
    NCHS Data Brief; 2017 Jan; (269):1-8. PubMed ID: 28135186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.